Literature DB >> 7523815

Risperidone-induced neuroleptic malignant syndrome.

P Webster, C Wijeratne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523815     DOI: 10.1016/s0140-6736(94)90542-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.

Authors:  N Bhana; C M Spencer
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  Antipsychotic treatment for late-life schizophrenia.

Authors:  Jeremy A Sable; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

Review 3.  The use of atypical antipsychotics in the management of schizophrenia.

Authors:  M Campbell; P I Young; D N Bateman; J M Smith; S H Thomas
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

Review 4.  Effects of newer antipsychotics on extrapyramidal function.

Authors:  Daniel Tarsy; Ross J Baldessarini; Frank I Tarazi
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Neuroleptic Malignant Syndrome: A Primary Care Perspective.

Authors:  Sanjay Gupta; Nikhil D Nihalani
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

6.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12

Review 7.  Recent developments in the management of psychosis.

Authors:  M J Hoes
Journal:  Pharm World Sci       Date:  1998-06

Review 8.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 9.  Adverse effects of antipsychotic agents. Do newer agents offer advantages?

Authors:  D G Owens
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

Review 10.  Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS).

Authors:  Jordan Klesmer; Ruxandra Badescu
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 8.081

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.